-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_executive.pdf
April 01, 2012 - Several retrospective observational studies
analyzed the long-term comparative effectiveness and
safety … safety was rarely available in RCTs, despite high
discontinuation rates suggesting that there were … drugs’ adverse
effects in clinical practice could provide information about
long-term comparative safety … • Evidence is insufficient for the long-term safety of
pharmacological treatments. … Safety profile of tolterodine as
used in general practice in England: results of prescription-event
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Although propofol may be preferred for these
reasons, safety concerns complicate its use. … benefits of wider access to
ES-4
propofol-mediated sedation were significant enough to offset safety … The intent is to improve
seniors’ safety, clinical outcomes, and quality of care and to reduce admissions … The primary endpoint
was a composite safety measure (area under the curve of oxygen desaturation [AUCDesat … the Sedasys can be used.7
The FDA approval requires that EES conduct two postmarketing studies on safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
January 01, 2016 - The safety of tests used to diagnose gout also needs to
be considered. … Potential safety concerns include acute
physical discomfort from joint aspiration and long-term
effects … Therefore, we have undertaken a systematic review of
studies examining the accuracy and safety of tests … The focus of this report is on evaluating the validity and
safety of existing diagnostic methods for … Summary of findings on comparative accuracy and safety
of gout diagnostic methods
Outcomes Level
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/arthritis-knee-physical-therapy_research-protocol.pdf
April 01, 2010 - integration or
reintegration
Injury prevention or reduction with use of
devices and equipment
Safety … o Long-term outcomes (>3 months)
• Settings
Outpatient and home-based care settings
• Safety … We will monitor the FDA Web site for warnings and safety information
for all eligible devices. … Evidence-based Practice Center Systematic Review Protocol
Outpatient and home-based care settings
• Safety
-
effectivehealthcare.ahrq.gov/sites/default/files/s29.pdf
October 01, 2007 - They pointed out that if existing evidence suggested
that 2 or more drugs had comparable efficacy and safety … whether less expensive is as effective)
Would not be a significant factor; medication effectiveness and safety … Would not have similar evidence-base for both drugs; 1 yr not sufficient to evaluate
safety or side effect … Choose study drugs (treatment arms) for which there is no evidence of
differential effectiveness or safety
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Novartis Pharmaceuticals. 16 week efficacy
and 2 year long term safety and efficacy of
secukinumab … Novartis Pharmaceuticals. 16 week efficacy
and 5 year long term efficacy, safety and
tolerability … anti-interleukin-17a
monoclonal antibody, improves active
psoriatic arthritis: 24-week efficacy and safety … antibody, improves active
psoriatic arthritis and inhibits radiographic
progression: efficacy and safety … 17a-monoclonal-antibody-improves-active-psoriatic-arthritis-and-inhibits-radiographic-progression-efficacy-and-safety-data-from-a-phase
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
September 30, 2010 - Minnesota
Pulsegen device Certificate of Approval for Use of GS Symbol No. 95 44
083; LGA, Equipment Safety … Twin (Vitacon AS, Trondheim, Norway)
Vaginal cones Mabella cones (Vitacon AS, Trond-heim, Norway)
Safety … We will monitor the FDA website for warnings and safety information for all
eligible drugs and devices … will analyze the harmful effects of drugs from
all sources including efficacy, effectiveness, and safety … Clinical efficacy and safety of tolterodine in the treatment of overactive
bladder: a pooled analysis
-
effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
January 01, 2012 - pricing than injectable biologic
therapies, but some experts expressed strong concerns regarding its safety … stated MSC therapy is
investigational because of insufficient evidence or insufficient long-term safety … Both groups had
similar safety profiles.
29
In a study of patients with knee OA (Outerbridge grades … such as a hospital
blood bank or blood processing laboratory) according to standard blood processing safety … These safety concerns could present significant barriers to diffusion.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
August 01, 2015 - Study design:
Allocation: Randomized
Endpoint Classification:
Safety/Efficacy Study
Intervention … Study design:
Endpoint Classification: Safety
Study
Intervention Model: Single Group
Assignment … Study design:
Allocation: Randomized
Endpoint Classification:
Safety/Efficacy Study
Intervention … Study design:
Allocation: Randomized
Endpoint Classification:
Safety/Efficacy Study
Intervention … Study design:
Allocation: Randomized
Endpoint Classification:
Safety/Efficacy Study
Intervention
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/long-term-care-adults_research-protocol.pdf
December 20, 2011 - medication administration, medication)
management
Activity program
General oversight and safety … medication administration, medication
management
Activity program
General oversight and safety … Reported harms are safety, inadequate preventive care, unnecessary hospitalizations,
and concerns about